Home / Inspections / 790419

FDA Inspection 790419 — Stason Pharmaceuticals, Inc.

Stason Pharmaceuticals, Inc. — FEI 1000160561

The FDA completed an inspection of Stason Pharmaceuticals, Inc. on July 12, 2012 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 12, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)

Facility

Other inspections at this facility

  • 1140029 (VAI Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1109969 (OAI Fri Oct 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067952 (NAI Fri Aug 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 960658 (VAI Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 911418 (VAI Thu Jan 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources